Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Hematopoietic cell lineage (mmu04640)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
AK038228
KLA  ATP  ATP+KLA
 AK038228 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130088F22 product:unclassifiable, full insert sequence [AK038228] KLA .39 .40 .25 .30 .32 .33 .40
ATP 2.17 3.59 2.77 1.97 3.23 2.18 1.60
KLA/ATP .41 .64 .69 .82 1.51 .90 1.17
Anpep
KLA  ATP  ATP+KLA
 NM_008486 alanyl (membrane) aminopeptidase (Anpep), mRNA [NM_008486] KLA .93 .81 .87 .91 1.05 1.06 .71
ATP .99 .98 1.00 1.08 1.04 .93 1.45
KLA/ATP .85 .89 .82 .97 .97 .93 .90
Cd14
KLA  ATP  ATP+KLA
 NM_009841 CD14 antigen (Cd14), mRNA [NM_009841] KLA 2.35 2.68 2.54 2.21 2.39 1.52 1.57
ATP 1.44 2.28 2.82 3.98 6.68 16.14 6.92
KLA/ATP 2.92 3.79 3.96 5.12 5.29 10.42 11.50
Cd19
KLA  ATP  ATP+KLA
 NM_009844 CD19 antigen (Cd19), mRNA [NM_009844] KLA 1.05 1.04 1.09 1.05 1.03 1.07 1.10
ATP 1.04 1.03 .99 1.07 .93 .97 .97
KLA/ATP 1.04 1.03 1.02 .97 1.01 1.00 1.08
Cd1d1
KLA  ATP  ATP+KLA
 NM_007639 CD1d1 antigen (Cd1d1), mRNA [NM_007639] KLA .95 .90 .80 1.08 .74 .76 1.79
ATP .95 .85 1.07 .98 1.39 2.59 1.13
KLA/ATP .74 .86 1.30 .96 1.29 2.07 2.82
Cd1d2
KLA  ATP  ATP+KLA
 NM_007640 CD1d2 antigen (Cd1d2), mRNA [NM_007640] KLA .93 .87 .93 .92 .87 .85 1.28
ATP .98 1.02 1.05 1.05 1.07 1.08 1.10
KLA/ATP .90 .90 .88 .92 .89 .99 1.28
Cd2
KLA  ATP  ATP+KLA
 NM_013486 CD2 antigen (Cd2), mRNA [NM_013486] KLA 1.03 1.01 1.04 1.03 1.00 1.06 .98
ATP .99 1.04 1.13 .98 .96 1.10 1.00
KLA/ATP .94 1.02 1.02 .95 1.04 .93 1.02
Cd22
KLA  ATP  ATP+KLA
 NM_009845 CD22 antigen (Cd22), transcript variant 2, mRNA [NM_009845] KLA .89 .90 .89 .90 .93 1.16 1.81
ATP 1.02 1.06 1.03 1.15 .96 .88 2.26
KLA/ATP .94 .92 .90 .97 .86 .90 1.15
Cd24a
KLA  ATP  ATP+KLA
 NM_009846 CD24a antigen (Cd24a), mRNA [NM_009846] KLA .81 .92 .77 .65 .48 .48 .83
ATP 1.12 1.21 1.46 2.00 2.69 2.88 2.41
KLA/ATP .83 .91 .88 1.24 1.19 1.39 2.01
Cd33
KLA  ATP  ATP+KLA
 NM_021293 CD33 antigen (Cd33), transcript variant 2, mRNA [NM_021293] KLA .97 1.02 1.26 1.40 1.50 1.11 .89
ATP 1.16 1.26 1.07 1.56 1.32 1.09 1.21
KLA/ATP 1.17 1.01 1.09 1.53 .98 1.06 1.33
Cd34
KLA  ATP  ATP+KLA
 NM_133654 CD34 antigen (Cd34), transcript variant 2, mRNA [NM_133654] KLA .94 .96 .84 .78 .75 .80 .62
ATP 1.05 1.10 1.57 1.40 1.24 1.07 .70
KLA/ATP .90 .93 1.10 .86 .95 .90 .85
Cd36
KLA  ATP  ATP+KLA
 L23108 CD36 antigen mRNA, complete cds. [L23108] KLA .75 .74 .73 .57 .51 .40 .54
ATP .94 .93 .74 .61 .63 1.01 2.07
KLA/ATP .70 .67 .53 .47 .40 .58 1.13
Cd36
KLA  ATP  ATP+KLA
 NM_007643 CD36 antigen (Cd36), mRNA [NM_007643] KLA .70 .75 .67 .54 .45 .35 .42
ATP 1.06 1.04 .73 .58 .62 .81 1.44
KLA/ATP .83 .73 .45 .46 .35 .45 .82
Cd37
KLA  ATP  ATP+KLA
 NM_007645 CD37 antigen (Cd37), mRNA [NM_007645] KLA .83 .92 1.05 .82 1.02 .90 1.38
ATP 1.13 1.44 .79 1.76 1.03 .64 .99
KLA/ATP 1.15 1.29 .57 1.62 .71 .65 1.11
Cd38
KLA  ATP  ATP+KLA
 NM_007646 CD38 antigen (Cd38), mRNA [NM_007646] KLA 3.61 5.39 8.63 9.62 24.42 36.25 76.13
ATP 1.00 1.05 1.36 1.70 2.26 8.41 7.84
KLA/ATP 4.45 4.89 5.01 7.93 5.74 14.08 40.05
Cd3d
KLA  ATP  ATP+KLA
 NM_013487 CD3 antigen, delta polypeptide (Cd3d), mRNA [NM_013487] KLA 1.01 1.05 1.00 .95 .98 1.03 1.02
ATP 1.02 .94 1.08 .99 .99 .94 1.05
KLA/ATP .93 .91 .99 .98 .96 .96 1.04
Cd3e
KLA  ATP  ATP+KLA
 NM_007648 CD3 antigen, epsilon polypeptide (Cd3e), mRNA [NM_007648] KLA 1.21 1.25 1.29 1.22 1.29 1.32 1.13
ATP .98 1.00 1.10 1.11 1.10 1.19 1.11
KLA/ATP 1.24 1.30 1.32 1.30 1.22 1.19 1.10
Cd3g
KLA  ATP  ATP+KLA
 NM_009850 CD3 antigen, gamma polypeptide (Cd3g), mRNA [NM_009850] KLA 1.05 1.01 .96 1.01 1.02 .99 .99
ATP .94 .97 .99 .99 .95 1.02 1.07
KLA/ATP .95 .92 1.08 1.03 1.01 1.01 .99
Cd4
KLA  ATP  ATP+KLA
 NM_013488 CD4 antigen (Cd4), mRNA [NM_013488] KLA .99 1.02 1.02 1.03 1.01 1.06 1.09
ATP 1.00 1.02 1.00 1.05 .96 .99 1.04
KLA/ATP 1.03 1.01 1.03 1.06 .97 .98 .98
Cd4
KLA  ATP  ATP+KLA
 X04836 gb|Mouse mRNA for T-cell surface glycoprotein CD4 (L3T4) [X04836] KLA .98 .91 .94 .96 .89 .92 1.03
ATP 1.11 1.07 1.02 .95 .90 .92 .88
KLA/ATP 1.04 1.00 1.01 .97 .90 1.02 .89
Cd44
KLA  ATP  ATP+KLA
 NM_009851 CD44 antigen (Cd44), transcript variant 1, mRNA [NM_009851] KLA 1.87 1.86 1.79 1.42 .99 .54 .67
ATP 1.05 1.16 1.24 1.67 1.79 1.37 .85
KLA/ATP 2.00 2.08 1.53 1.86 1.24 .89 .71
Cd5
KLA  ATP  ATP+KLA
 NM_007650 CD5 antigen (Cd5), mRNA [NM_007650] KLA 1.01 1.06 .94 .98 1.08 1.00 .95
ATP 1.02 1.01 1.29 1.38 1.53 1.16 1.23
KLA/ATP .93 1.02 1.13 1.14 1.00 1.00 2.19
Cd55
KLA  ATP  ATP+KLA
 AF143541 decay accelerating factor glycosylphoshatidylinositol-anchored form (DAF) mRNA, partial cds. [AF143541] KLA .98 1.01 1.05 1.08 .98 .99 1.03
ATP 1.01 1.00 .95 .96 1.04 1.06 1.00
KLA/ATP 1.01 .99 1.05 .97 1.03 .97 .96
Cd55
KLA  ATP  ATP+KLA
 AK030285 11 days pregnant adult female ovary and uterus cDNA, RIKEN full-length enriched library, clone:5031405O06 product:decay accelerating factor 1, full insert sequence [AK030285] KLA 1.28 1.22 1.35 1.29 1.26 1.42 2.37
ATP 1.02 .96 1.02 1.00 .92 .98 1.32
KLA/ATP 1.30 1.22 1.19 1.04 .96 1.02 1.33
Cd55
KLA  ATP  ATP+KLA
 NM_010016 CD55 antigen (Cd55), mRNA [NM_010016] KLA 1.81 1.70 1.81 1.92 2.16 2.13 4.63
ATP 1.09 1.04 1.16 1.05 1.14 1.32 1.92
KLA/ATP 1.80 1.89 1.79 1.56 1.26 1.39 3.24
Cd59a
KLA  ATP  ATP+KLA
 NM_007652 CD59a antigen (Cd59a), transcript variant 2, mRNA [NM_007652] KLA .80 .80 .76 .72 .65 .66 .75
ATP .94 .91 1.06 .99 .89 .69 1.34
KLA/ATP .78 .77 .88 .77 .71 .52 .85
Cd59b
KLA  ATP  ATP+KLA
 NM_181858 CD59b antigen (Cd59b), mRNA [NM_181858] KLA .92 .91 .92 .93 .89 .94 .88
ATP .98 1.00 1.02 1.01 .91 .92 .94
KLA/ATP .90 .91 .95 .91 .89 .86 .86
Cd7
KLA  ATP  ATP+KLA
 NM_009854 CD7 antigen (Cd7), mRNA [NM_009854] KLA 1.03 1.09 1.09 1.02 1.00 1.00 1.13
ATP 1.05 1.15 1.14 1.32 1.05 1.06 1.13
KLA/ATP 1.02 1.04 1.17 1.13 1.02 .92 1.12
Cd8a
KLA  ATP  ATP+KLA
 NM_001081110 CD8 antigen, alpha chain (Cd8a), mRNA [NM_001081110] KLA 1.02 1.03 1.04 1.04 1.07 1.03 1.02
ATP 1.01 .98 .99 1.03 1.01 1.00 .99
KLA/ATP 1.02 1.01 1.04 1.03 1.06 1.06 1.00
Cd8b1
KLA  ATP  ATP+KLA
 M17534 gb|Mouse T-cell membrane glycoprotein (Ly-3) mRNA, complete cds. [M17534] KLA 1.04 1.06 1.11 1.12 1.07 1.06 .95
ATP 1.00 1.07 .97 .97 .96 1.05 .98
KLA/ATP .96 1.02 1.07 1.03 1.05 .95 .97
Cd9
KLA  ATP  ATP+KLA
 AK080546 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730082P15 product:CD9 antigen, full insert sequence [AK080546] KLA 1.05 1.04 1.04 .95 1.03 1.04 .94
ATP .94 .98 .98 .98 1.04 .99 1.06
KLA/ATP .90 .98 1.04 1.09 1.01 .95 1.04
Cd9
KLA  ATP  ATP+KLA
 NM_007657 CD9 antigen (Cd9), mRNA [NM_007657] KLA .92 .83 .83 .73 .57 .38 .10
ATP 1.02 .95 1.30 1.17 1.32 1.91 1.96
KLA/ATP .82 .82 1.02 .91 .98 .93 .95
Cr2
KLA  ATP  ATP+KLA
 NM_007758 complement receptor 2 (Cr2), mRNA [NM_007758] KLA .98 .98 .99 1.01 1.00 .99 1.02
ATP 1.03 .99 .94 1.01 1.02 .95 .99
KLA/ATP 1.04 1.07 1.07 1.08 1.06 1.04 .93
Csf1
KLA  ATP  ATP+KLA
 NM_007778 colony stimulating factor 1 (macrophage) (Csf1), transcript variant 1, mRNA [NM_007778] KLA 18.44 16.94 15.74 12.71 7.63 6.20 2.51
ATP 1.04 1.22 4.90 14.80 12.10 10.26 6.73
KLA/ATP 16.93 18.17 20.56 19.41 18.03 15.99 12.59
Csf1r
KLA  ATP  ATP+KLA
 NM_001037859 colony stimulating factor 1 receptor (Csf1r), mRNA [NM_001037859] KLA .76 .81 .88 .67 .74 .78 .90
ATP 1.10 1.22 .88 1.10 .87 .78 1.28
KLA/ATP .97 .87 .63 .83 .51 .66 1.18
Csf2
KLA  ATP  ATP+KLA
 NM_009969 colony stimulating factor 2 (granulocyte-macrophage) (Csf2), mRNA [NM_009969] KLA 1.44 1.53 1.38 1.37 1.15 1.21 1.14
ATP 1.01 1.02 1.85 9.73 2.64 1.90 1.14
KLA/ATP 1.49 1.84 2.14 2.80 1.67 1.36 1.35
Csf2ra
KLA  ATP  ATP+KLA
 NM_009970 colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) (Csf2ra), mRNA [NM_009970] KLA 1.10 1.06 1.03 1.13 1.24 1.35 1.09
ATP .89 .87 .95 .81 .86 1.10 1.06
KLA/ATP .94 .98 1.22 1.02 1.18 1.11 1.22
Csf3
KLA  ATP  ATP+KLA
 NM_009971 colony stimulating factor 3 (granulocyte) (Csf3), mRNA [NM_009971] KLA 1.44 1.56 2.06 2.25 2.97 1.58 1.55
ATP 1.04 1.05 1.14 2.18 4.85 7.52 1.83
KLA/ATP 1.54 1.93 2.57 4.75 3.85 3.95 7.39
Csf3r
KLA  ATP  ATP+KLA
 NM_007782 colony stimulating factor 3 receptor (granulocyte) (Csf3r), mRNA [NM_007782] KLA 4.44 4.65 6.62 6.79 9.58 9.08 7.39
ATP 1.27 1.26 1.06 1.43 1.13 1.07 1.28
KLA/ATP 5.07 5.53 4.84 7.70 3.86 3.49 7.22
Daf2
KLA  ATP  ATP+KLA
 AK019553 adult male testis cDNA, RIKEN full-length enriched library, clone:4921540H11 product:decay accelerating factor 2, full insert sequence. [AK019553] KLA 1.04 .91 .97 .98 1.02 1.02 .95
ATP .97 1.03 .91 .96 .95 1.05 1.05
KLA/ATP .94 .99 1.00 1.00 .99 .97 1.02
Daf2
KLA  ATP  ATP+KLA
 NM_007827 decay accelerating factor 2 (Daf2), mRNA [NM_007827] KLA 1.06 .99 1.00 1.00 1.03 1.04 1.18
ATP 1.03 1.03 .93 1.05 .97 .85 .98
KLA/ATP 1.11 1.13 1.10 1.00 .93 1.05 1.02
Dntt
KLA  ATP  ATP+KLA
 NM_001043228 deoxynucleotidyltransferase, terminal (Dntt), transcript variant 2, mRNA [NM_001043228] KLA 1.01 1.00 1.02 1.01 1.02 1.00 1.07
ATP .94 1.03 1.08 .99 1.08 1.09 1.05
KLA/ATP 1.00 1.00 1.01 1.04 1.06 1.05 1.12
Dntt
KLA  ATP  ATP+KLA
 NM_009345 deoxynucleotidyltransferase, terminal (Dntt), transcript variant 1, mRNA [NM_009345] KLA 1.22 1.15 1.23 1.25 1.17 1.15 1.12
ATP 1.09 1.03 1.27 1.22 2.08 2.71 1.39
KLA/ATP 1.19 1.21 1.44 1.29 1.60 2.51 1.92
EG629860
KLA  ATP  ATP+KLA
 M17953 gb|Mouse Ig rearranged H-chain V-region mRNA VJ1 [M17953] KLA .96 1.05 1.03 1.08 1.08 1.02 .98
ATP .97 .99 1.05 1.10 .95 .94 .91
KLA/ATP .96 .94 .97 1.04 .97 1.01 .89
Epo
KLA  ATP  ATP+KLA
 NM_007942 erythropoietin (Epo), mRNA [NM_007942] KLA 1.00 1.05 1.08 1.01 1.03 1.08 1.04
ATP .95 .97 .97 1.04 1.02 .99 1.01
KLA/ATP 1.03 1.01 .97 1.00 1.00 1.10 1.00
Epor
KLA  ATP  ATP+KLA
 NM_010149 erythropoietin receptor (Epor), mRNA [NM_010149] KLA .57 .56 .59 .66 .59 .52 .36
ATP 1.06 1.01 1.00 .95 .73 .52 .40
KLA/ATP .57 .53 .70 .66 .72 .62 .34
Fcer2a
KLA  ATP  ATP+KLA
 NM_013517 Fc receptor, IgE, low affinity II, alpha polypeptide (Fcer2a), mRNA [NM_013517] KLA .99 .99 1.03 .98 .92 1.00 .95
ATP .96 .96 .97 1.02 1.00 .98 .97
KLA/ATP .99 1.04 1.02 1.01 .95 .92 .95
Fcgr1
KLA  ATP  ATP+KLA
 AF143181 strain AB/H (Biozzi) high affinity immunoglobulin gamma Fc receptor I (Fcgr1) mRNA, Fcgr1-d allele, complete cds. [AF143181] KLA 4.27 4.21 5.59 6.14 8.13 9.76 10.98
ATP 1.23 1.12 1.08 1.36 1.09 2.09 11.81
KLA/ATP 4.56 4.93 4.95 5.88 6.66 9.64 23.09
Fcgr1
KLA  ATP  ATP+KLA
 NM_010186 Fc receptor, IgG, high affinity I (Fcgr1), mRNA [NM_010186] KLA 4.31 4.37 4.70 5.97 6.59 10.06 8.67
ATP 1.01 .88 1.16 .89 .90 2.15 9.23
KLA/ATP 4.01 4.10 5.52 4.54 6.31 9.24 15.83
Flt3
KLA  ATP  ATP+KLA
 NM_010229 FMS-like tyrosine kinase 3 (Flt3), mRNA [NM_010229] KLA .99 1.01 1.05 1.01 1.05 1.01 1.01
ATP .92 .98 1.09 1.12 1.00 1.02 1.03
KLA/ATP 1.04 .99 .89 1.01 .99 .94 1.05
Flt3l
KLA  ATP  ATP+KLA
 NM_013520 FMS-like tyrosine kinase 3 ligand (Flt3l), mRNA [NM_013520] KLA 1.08 1.12 1.37 1.32 1.68 1.86 1.67
ATP 1.08 1.03 1.05 1.22 .90 .71 1.26
KLA/ATP 1.12 1.16 1.20 1.22 1.09 .91 1.29
Gp1ba
KLA  ATP  ATP+KLA
 NM_010326 glycoprotein 1b, alpha polypeptide (Gp1ba), mRNA [NM_010326] KLA .92 1.01 .99 1.00 1.02 1.03 1.08
ATP 1.00 1.09 .97 .98 1.03 .99 1.09
KLA/ATP 1.03 1.04 1.08 1.08 .97 1.06 .97
Gp1bb
KLA  ATP  ATP+KLA
 NM_001001999 glycoprotein Ib, beta polypeptide (Gp1bb), transcript variant 1, mRNA [NM_001001999] KLA 1.03 1.04 1.10 1.03 1.16 1.17 1.15
ATP .99 .99 1.05 1.17 1.12 1.23 1.09
KLA/ATP 1.05 1.11 1.10 1.16 1.10 1.15 1.21
Gp5
KLA  ATP  ATP+KLA
 NM_008148 glycoprotein 5 (platelet) (Gp5), mRNA [NM_008148] KLA .93 1.00 1.04 1.01 .99 1.00 .96
ATP 1.04 .99 1.07 1.41 1.30 1.22 1.05
KLA/ATP 1.01 1.07 1.04 1.12 1.15 1.33 1.11
Gp9
KLA  ATP  ATP+KLA
 NM_018762 glycoprotein 9 (platelet) (Gp9), mRNA [NM_018762] KLA 1.07 1.00 1.05 1.02 1.09 .98 1.02
ATP .97 .97 1.03 1.02 1.03 1.00 1.01
KLA/ATP 1.04 1.02 1.05 1.06 1.07 .93 1.06
H2-Eb1
KLA  ATP  ATP+KLA
 X52641 gb|Mouse mRNA for I-A beta NOD. [X52641] KLA 1.94 2.06 1.94 1.87 1.96 2.18 1.76
ATP 1.11 1.20 1.53 2.70 3.02 2.91 1.40
KLA/ATP 2.09 2.11 2.26 3.55 2.76 3.05 3.05
Igh-VJ55
8
KLA  ATP  ATP+KLA
 AY547436 immunoglobulin heavy chain VDJ region mRNA, partial cds [AY547436] KLA 1.06 1.05 1.01 .93 1.03 .96 .93
ATP .99 1.00 1.06 .95 .96 1.06 1.05
KLA/ATP .98 .94 1.07 .95 .97 .99 1.02
Igh-VJ55
8
KLA  ATP  ATP+KLA
 CA578712 gb|K0727F04-5N NIA Mouse Hematopoietic Stem Cell (Lin- [CA578712] KLA .99 .94 1.01 1.10 .93 .97 .92
ATP .93 1.04 1.01 .98 1.05 .96 .95
KLA/ATP .99 .95 .95 .98 1.02 .98 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103412 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHA] [ENSMUST00000103412] KLA 1.01 .97 1.20 1.01 .98 1.44 1.24
ATP .99 .98 1.07 1.03 1.00 1.01 1.21
KLA/ATP .99 1.02 .96 1.03 .97 1.13 1.30
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103413 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHE] [ENSMUST00000103413] KLA 1.00 .99 1.06 1.06 .99 1.03 1.02
ATP 1.08 1.06 1.06 1.06 1.02 1.06 .95
KLA/ATP 1.00 1.04 1.09 1.02 1.06 1.02 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 U39781 J558+ IgM heavy chain mRNA, hybridoma clone ME2B7, partial cds. [U39781] KLA .93 .89 .98 .97 1.03 1.00 .94
ATP 1.04 1.02 1.08 .94 .93 .90 .79
KLA/ATP .88 .89 .97 .93 .88 .92 .82
Il11
KLA  ATP  ATP+KLA
 NM_008350 interleukin 11 (Il11), mRNA [NM_008350] KLA .98 1.04 1.03 1.03 .96 1.01 1.02
ATP .94 .97 1.07 1.15 1.18 1.19 1.09
KLA/ATP 1.03 1.10 1.06 1.29 1.72 2.17 1.23
Il11ra1
KLA  ATP  ATP+KLA
 NM_010549 interleukin 11 receptor, alpha chain 1 (Il11ra1), mRNA [NM_010549] KLA .65 .63 .59 .66 .66 .75 .57
ATP .93 .86 1.11 1.02 1.65 2.34 1.14
KLA/ATP .56 .66 .88 .71 1.75 2.07 1.00
Il1a
KLA  ATP  ATP+KLA
 NM_010554 interleukin 1 alpha (Il1a), mRNA [NM_010554] KLA 32.45 35.22 31.30 20.95 28.57 18.36 19.02
ATP 1.04 1.02 2.21 5.46 11.06 32.07 3.40
KLA/ATP 32.02 41.20 35.12 46.91 28.76 42.72 57.80
Il1b
KLA  ATP  ATP+KLA
 NM_008361 interleukin 1 beta (Il1b), mRNA [NM_008361] KLA 149.78 133.59 100.91 116.58 86.48 89.37 64.72
ATP 3.49 13.96 61.44 70.91 82.12 162.79 28.18
KLA/ATP 130.32 139.00 219.12 148.17 165.44 172.57 146.98
Il1r1
KLA  ATP  ATP+KLA
 NM_008362 interleukin 1 receptor, type I (Il1r1), transcript variant 1, mRNA [NM_008362] KLA 1.20 1.08 1.22 1.52 2.19 2.32 1.61
ATP 1.10 .96 1.18 1.56 8.14 9.56 7.54
KLA/ATP 1.22 1.13 1.37 1.85 4.54 6.85 8.96
Il1r2
KLA  ATP  ATP+KLA
 NM_010555 interleukin 1 receptor, type II (Il1r2), mRNA [NM_010555] KLA 1.05 1.03 1.08 1.13 1.09 1.08 1.14
ATP 1.03 1.08 1.30 1.68 1.38 1.10 1.19
KLA/ATP 1.08 1.14 1.17 1.27 1.10 1.11 2.03
Il2ra
KLA  ATP  ATP+KLA
 AF054581 interleukin 2 receptor mRNA, 3UTR, partial sequence. [AF054581] KLA 1.76 2.05 2.73 2.46 3.58 2.68 1.13
ATP .99 .99 1.00 1.09 1.13 1.14 1.03
KLA/ATP 1.93 2.11 1.32 2.27 1.87 2.13 1.37
Il2ra
KLA  ATP  ATP+KLA
 NM_008367 interleukin 2 receptor, alpha chain (Il2ra), mRNA [NM_008367] KLA 1.33 1.29 1.46 1.43 1.82 1.57 1.15
ATP 1.02 1.03 1.01 1.02 1.01 1.12 1.05
KLA/ATP 1.30 1.46 1.36 1.41 1.22 1.47 1.66
Il3
KLA  ATP  ATP+KLA
 NM_010556 interleukin 3 (Il3), mRNA [NM_010556] KLA 1.05 .94 1.01 .99 1.03 1.07 .95
ATP .95 1.03 1.03 .98 .98 .97 .96
KLA/ATP 1.02 1.03 1.02 .94 .97 1.02 1.04
Il3ra
KLA  ATP  ATP+KLA
 NM_008369 interleukin 3 receptor, alpha chain (Il3ra), mRNA [NM_008369] KLA 1.23 1.35 1.52 1.31 1.38 1.42 1.35
ATP 1.04 1.20 1.11 1.42 1.18 .94 .77
KLA/ATP 1.33 1.45 1.45 1.69 1.25 1.22 1.32
Il4
KLA  ATP  ATP+KLA
 NM_021283 interleukin 4 (Il4), mRNA [NM_021283] KLA .94 .95 .91 .94 .91 .94 1.07
ATP 1.02 1.06 1.05 1.22 1.12 1.10 1.26
KLA/ATP .92 .96 .93 1.08 .98 1.03 1.18
Il4ra
KLA  ATP  ATP+KLA
 NM_001008700 interleukin 4 receptor, alpha (Il4ra), mRNA [NM_001008700] KLA 4.65 4.81 8.69 11.26 14.81 9.10 1.64
ATP .97 .88 .64 .58 3.81 9.28 4.93
KLA/ATP 4.86 4.84 5.43 3.60 4.37 10.35 6.16
Il5
KLA  ATP  ATP+KLA
 NM_010558 interleukin 5 (Il5), mRNA [NM_010558] KLA 1.10 1.11 1.10 .98 1.01 .98 .97
ATP .94 1.04 1.08 .92 .97 1.02 1.03
KLA/ATP .98 .92 1.12 1.03 1.02 1.00 1.03
Il5ra
KLA  ATP  ATP+KLA
 NM_008370 interleukin 5 receptor, alpha (Il5ra), mRNA [NM_008370] KLA 1.09 1.05 1.10 1.06 .98 1.00 .97
ATP .95 1.02 .99 .97 .99 1.01 .99
KLA/ATP .99 1.06 1.09 1.00 1.03 .99 1.07
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Il6ra
KLA  ATP  ATP+KLA
 NM_010559 interleukin 6 receptor, alpha (Il6ra), mRNA [NM_010559] KLA .50 .53 .65 .86 1.36 1.72 1.00
ATP .97 1.20 1.17 1.25 .74 .67 .95
KLA/ATP .50 .60 .61 .64 .59 .76 1.14
Il7
KLA  ATP  ATP+KLA
 AK041403 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630007F02 product:interleukin 7, full insert sequence [AK041403] KLA .96 .96 .97 1.00 1.01 .97 1.08
ATP 1.05 1.00 .98 .99 .94 .98 .95
KLA/ATP 1.05 1.05 .96 .99 .94 .99 .92
Il7
KLA  ATP  ATP+KLA
 NM_008371 interleukin 7 (Il7), mRNA [NM_008371] KLA 1.29 1.38 1.32 1.39 1.24 1.40 1.26
ATP 1.01 .98 1.02 .98 1.03 1.10 1.08
KLA/ATP 1.22 1.31 1.17 1.20 1.04 1.21 1.32
Il7r
KLA  ATP  ATP+KLA
 AK041838 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630041A17 product:interleukin 7 receptor, full insert sequence. [AK041838] KLA .90 1.04 .92 .95 .90 1.05 .99
ATP .97 1.01 1.11 1.04 1.06 1.33 2.92
KLA/ATP .98 .97 .91 1.10 1.06 1.20 1.57
Il7r
KLA  ATP  ATP+KLA
 NM_008372 interleukin 7 receptor (Il7r), mRNA [NM_008372] KLA .42 .40 .37 .41 .36 .60 .73
ATP 1.02 1.01 1.23 1.13 1.72 2.94 7.90
KLA/ATP .40 .41 .53 .58 1.00 2.18 4.13
Il9r
KLA  ATP  ATP+KLA
 NM_008374 interleukin 9 receptor (Il9r), mRNA [NM_008374] KLA 1.01 1.02 1.01 1.02 1.01 1.01 .94
ATP .97 1.03 1.01 .94 .98 1.05 1.02
KLA/ATP 1.02 .95 1.01 1.03 1.01 .95 1.04
Itga1
KLA  ATP  ATP+KLA
 NM_001033228 integrin alpha 1 (Itga1), mRNA [NM_001033228] KLA 1.08 1.09 1.13 1.05 1.04 .99 1.01
ATP 1.02 .97 1.03 1.03 1.09 1.43 3.50
KLA/ATP 1.06 1.04 1.07 1.00 1.06 1.12 1.33
Itga2
KLA  ATP  ATP+KLA
 NM_008396 integrin alpha 2 (Itga2), mRNA [NM_008396] KLA 1.03 1.00 .98 1.01 .97 .96 1.00
ATP 1.05 .99 .93 1.02 1.04 1.03 .97
KLA/ATP .98 1.06 1.03 1.00 1.00 1.01 1.01
Itga2b
KLA  ATP  ATP+KLA
 NM_010575 integrin alpha 2b (Itga2b), mRNA [NM_010575] KLA 1.01 1.00 .98 1.04 1.01 1.04 1.18
ATP 1.01 .98 .95 1.02 .96 1.13 1.08
KLA/ATP 1.04 1.02 1.02 .95 1.05 1.53 1.23
Itga3
KLA  ATP  ATP+KLA
 NM_013565 integrin alpha 3 (Itga3), mRNA [NM_013565] KLA 1.06 1.09 1.10 1.17 1.19 1.29 1.41
ATP .99 .99 1.05 1.12 1.20 1.25 1.33
KLA/ATP 1.08 1.14 1.15 1.27 1.28 1.20 1.39
Itga4
KLA  ATP  ATP+KLA
 NM_010576 integrin alpha 4 (Itga4), mRNA [NM_010576] KLA 4.65 4.83 4.47 3.76 2.93 1.65 1.01
ATP 1.10 1.12 1.17 1.08 .86 .75 .36
KLA/ATP 4.82 5.02 4.43 3.69 2.11 1.13 .79
Itga5
KLA  ATP  ATP+KLA
 NM_010577 integrin alpha 5 (fibronectin receptor alpha) (Itga5), mRNA [NM_010577] KLA 2.63 3.04 2.81 2.47 4.61 5.45 4.90
ATP 1.13 1.62 .74 2.21 1.31 1.93 2.84
KLA/ATP 3.55 3.84 1.15 3.03 1.11 2.81 10.42
Itga6
KLA  ATP  ATP+KLA
 BC024571 integrin alpha 6, mRNA (cDNA clone IMAGE:5036677). [BC024571] KLA .44 .44 .37 .28 .25 .29 .34
ATP .96 1.01 .90 .58 .35 .11 .22
KLA/ATP .44 .41 .34 .23 .15 .09 .08
Itga6
KLA  ATP  ATP+KLA
 NM_008397 integrin alpha 6 (Itga6), mRNA [NM_008397] KLA .57 .58 .51 .45 .43 .44 .47
ATP 1.05 1.12 .86 .90 .57 .27 .36
KLA/ATP .64 .67 .50 .57 .39 .29 .26
Itgam
KLA  ATP  ATP+KLA
 NM_001082960 integrin alpha M (Itgam), transcript variant 1, mRNA [NM_001082960] KLA 1.04 1.12 1.14 1.07 1.54 1.80 1.72
ATP 1.17 1.19 .97 1.16 .86 .65 1.33
KLA/ATP 1.19 1.19 .94 1.06 .64 .59 1.08
Itgam
KLA  ATP  ATP+KLA
 NM_008401 integrin alpha M (Itgam), transcript variant 2, mRNA [NM_008401] KLA 1.20 1.16 1.21 1.34 1.59 1.79 1.64
ATP 1.15 1.16 .94 1.20 1.00 .78 1.25
KLA/ATP 1.32 1.37 1.29 1.14 .84 .75 1.16
Itgb3
KLA  ATP  ATP+KLA
 AF026509 integrin beta3 subunit mRNA, complete cds. [AF026509] KLA 2.38 2.64 2.65 3.15 4.02 4.46 2.83
ATP 1.21 1.17 1.25 1.62 2.33 3.09 4.78
KLA/ATP 2.48 2.63 3.39 3.72 4.30 4.71 6.79
Itgb3
KLA  ATP  ATP+KLA
 NM_016780 integrin beta 3 (Itgb3), mRNA [NM_016780] KLA .50 .51 .52 .41 .31 .25 .15
ATP .94 .88 1.17 .89 .99 1.36 .91
KLA/ATP .51 .54 .67 .52 .61 .74 .48
Kit
KLA  ATP  ATP+KLA
 Y00864 gb|Mouse c-kit mRNA. [Y00864] KLA .88 .86 .83 .76 .75 .73 .87
ATP 1.06 1.07 1.03 1.04 3.95 1.93 1.25
KLA/ATP .87 .87 .89 .89 1.06 1.08 .91
Kitl
KLA  ATP  ATP+KLA
 NM_013598 kit ligand (Kitl), mRNA [NM_013598] KLA .49 .46 .43 .38 .23 .35 .46
ATP .89 .85 .79 .91 1.14 1.30 .86
KLA/ATP .48 .43 .49 .96 1.59 1.38 .95
Mm.1233
KLA  ATP  ATP+KLA
 158508444 Unknown KLA .97 .97 .95 .98 1.04 1.00 .93
ATP 1.03 1.08 1.29 1.57 1.01 .96 1.21
KLA/ATP .97 1.00 1.58 1.65 .96 .91 .86
Mm.19345
1
KLA  ATP  ATP+KLA
 141802044 Unknown KLA .67 .64 .57 .63 .57 .75 .54
ATP .88 .81 1.15 .97 1.46 2.27 1.19
KLA/ATP .55 .60 .84 .67 1.75 2.01 .95
Mm.21036
1
KLA  ATP  ATP+KLA
 158508719 Unknown KLA 1.12 1.15 1.09 1.20 1.18 1.33 1.23
ATP 1.05 1.18 1.10 1.41 1.26 1.25 1.23
KLA/ATP 1.22 1.40 1.22 1.54 1.24 1.28 1.49
Mm.24987
3
KLA  ATP  ATP+KLA
 161621251 Unknown KLA 1.11 1.02 1.08 1.36 1.47 1.64 3.59
ATP 1.05 1.00 1.00 .96 1.04 1.20 1.13
KLA/ATP 1.08 1.12 1.23 1.06 1.09 1.31 1.81
Mm.28722
8
KLA  ATP  ATP+KLA
 160707972 Unknown KLA 1.08 1.08 1.05 1.13 1.29 1.37 1.09
ATP 1.04 .96 1.15 .83 .88 1.18 1.09
KLA/ATP 1.06 .86 1.30 1.05 1.19 1.00 1.19
Mm.29798
KLA  ATP  ATP+KLA
 161484605 Unknown KLA .94 .94 .80 .86 .71 .87 .67
ATP 1.01 1.01 1.53 1.48 1.31 1.06 .75
KLA/ATP .93 .95 .95 .89 .87 .92 .78
Mm.33314
8
KLA  ATP  ATP+KLA
 118129874 Unknown KLA 1.04 1.03 1.05 1.08 1.05 1.02 1.00
ATP .95 1.08 .99 .91 .96 1.03 1.07
KLA/ATP .99 1.00 1.02 .98 1.00 .98 1.10
Mm.384
KLA  ATP  ATP+KLA
 197333823 Unknown KLA 1.04 1.03 .99 1.02 1.00 .91 .99
ATP 1.03 .99 1.02 .97 1.00 .91 .97
KLA/ATP 1.03 1.10 1.01 1.01 1.01 .87 1.00
Mm.47583
0
KLA  ATP  ATP+KLA
 188497639 Unknown KLA 1.25 1.20 1.19 1.12 1.06 1.16 1.15
ATP 1.29 1.35 1.22 1.23 1.00 .97 .94
KLA/ATP 1.30 1.31 1.35 1.17 1.02 .96 1.01
Mme
KLA  ATP  ATP+KLA
 NM_008604 membrane metallo endopeptidase (Mme), mRNA [NM_008604] KLA 1.01 1.04 1.00 1.02 1.02 .98 .98
ATP .95 .98 .97 .99 1.04 .96 1.01
KLA/ATP 1.04 1.06 1.05 1.01 .98 .91 1.00
Ms4a1
KLA  ATP  ATP+KLA
 M62541 gb|Mouse CD20 cell surface protein mRNA, complete cds. [M62541] KLA .99 1.04 1.00 1.03 1.07 1.13 .98
ATP .97 1.10 .97 .92 .89 1.12 1.26
KLA/ATP 1.05 .99 1.12 1.11 1.04 1.19 1.82
Ms4a1
KLA  ATP  ATP+KLA
 NM_007641 membrane-spanning 4-domains, subfamily A, member 1 (Ms4a1), mRNA [NM_007641] KLA 1.08 1.02 1.05 1.11 1.11 1.24 1.17
ATP .96 1.06 .97 .97 .96 1.16 1.59
KLA/ATP .97 .99 1.15 1.14 1.13 1.57 2.43
Siglech
KLA  ATP  ATP+KLA
 NM_178706 sialic acid binding Ig-like lectin H (Siglech), mRNA [NM_178706] KLA 1.12 1.04 1.11 .99 1.01 .98 .97
ATP 1.06 1.12 1.14 1.02 .99 .97 1.02
KLA/ATP 1.01 1.04 1.09 1.03 .94 .92 1.00
Tfrc
KLA  ATP  ATP+KLA
 NM_011638 transferrin receptor (Tfrc), mRNA [NM_011638] KLA .77 .79 .86 .63 .45 .25 .31
ATP 1.07 1.11 1.09 .89 .75 .45 .17
KLA/ATP .89 .85 .77 .66 .40 .24 .09
Thpo
KLA  ATP  ATP+KLA
 NM_009379 thrombopoietin (Thpo), mRNA [NM_009379] KLA .96 .98 .95 .98 1.07 1.04 1.00
ATP 1.02 1.11 1.03 1.22 1.16 1.05 1.03
KLA/ATP 1.05 .96 1.08 1.22 1.13 1.01 1.03
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07
Tpo
KLA  ATP  ATP+KLA
 NM_009417 thyroid peroxidase (Tpo), mRNA [NM_009417] KLA 1.05 1.05 .87 1.01 1.00 1.03 1.04
ATP 1.03 .95 .99 1.02 1.00 1.00 .91
KLA/ATP 1.01 .99 1.01 1.01 .93 .96 .93